Heron Therapeutics, Inc. (HRTX)
0.4386
-0.01
(-2.53%)
USD |
NASDAQ |
Jun 03, 16:00
0.445
+0.01
(+1.46%)
After-Hours: 18:46
Heron Therapeutics EPS Diluted (Quarterly) : -0.0428 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.2446 |
| ARS Pharmaceuticals, Inc. | -0.6105 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.111M |
| Revenue (Quarterly) | 34.71M |
| Total Expenses (Quarterly) | 42.82M |
| Enterprise Value | 183.08M |
| Gross Profit Margin (Quarterly) | 69.35% |
| Profit Margin (Quarterly) | -23.37% |
| Earnings Yield | -40.29% |
| Normalized Earnings Yield | -29.16 |